Yayınlanmış 1 Ocak 2017 | Sürüm v1
Dergi makalesi Açık

Preparation and In Vitro/In Vivo Evaluation of Rofecoxib Containing Bovine Serum Albumin Microspheres

  • 1. Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey

Açıklama

Rofecoxib, apart from its antiinflamatory, analgesic and antipyretic activity, is a Class II drug according to the BCS and suitable for being formulated as microspheres with bovine serum albumin. In this study, rofecoxib microsphere formulations were developed and characterized. One of the prepared formulations that has a particle size of 13.48 +/- 2.11 mu m, 35.20 +/- 1.32% of encapsulation efficiency and better- sustained release (up to 18 h) was chosen for the in vivo experiments. A Level A IVIVC was evaluated between the in vitro dissolution and in vivo plasma concentration-time profile data. Linear regression analysis showed a statistically significant relationship between the in vitro dissolved percentages and in vivo absorbed percentages of the drug and the best fitted equation was described.

Dosyalar

bib-10b715ef-3338-41eb-a28e-0ef29af58a9f.txt

Dosyalar (233 Bytes)

Ad Boyut Hepisini indir
md5:da4d267877f03357f23ab5b0606046fa
233 Bytes Ön İzleme İndir